But they also found that psychedelics as well as SSRI’s don’t have the same results in everyone – and genes could explain why. The researchers identified the primary receptor that psychedelics bind to in the human body: 5-HT2A which shares an almost identical chemical structure to serotonin. They also found that the gene variants they analyzed reflected mutations in a genome known as the single nucleotide polymorphism (SNP); the mutations were 7 alleles that are found in the biology of most human beings, explains Gavin Schmitz, first author of the paper.
Cannabis can make ideas feel unusually profound by loosening self-criticism, everyday logic and the mental…
Teen cannabis use has fallen across three national surveys while legal markets have opened. At…
A new collaboration brings together iconic functional glass, carefully selected cannabis genetics and a mission…
This interview by Micah Johnson originally appeared in High Times Local, produced under license by…
Congress's watchdog confirmed the DEA has no complete written procedures for drug scheduling. Learn why…
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…